LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

Search

Cencora Inc

Fermé

SecteurSoins de santé

370.83 1.17

Résumé

Variation du prix de l'action

24h

Actuel

Min

369.63

Max

373.91

Chiffres clés

By Trading Economics

Revenu

906M

566M

Ventes

2.2B

86B

P/E

Moyenne du Secteur

43.836

108.767

BPA

2.87

Rendement du dividende

0.62

Marge bénéficiaire

0.659

Employés

47,000

EBITDA

858M

1B

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+14.14% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

0.62%

2.21%

Prochains Résultats

6 mai 2026

Date du Prochain Dividende

2 mars 2026

Date du Prochain Détachement de Dividende

15 mai 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

482M

71B

Ouverture précédente

369.66

Clôture précédente

370.83

Sentiment de l'Actualité

By Acuity

34%

66%

80 / 352 Classement par Healthcare

Cencora Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

27 févr. 2026, 23:53 UTC

Actions en Tendance

Stocks to Watch: Aardvark Therapeutics, Blue Moon Metals

27 févr. 2026, 22:23 UTC

Acquisitions, Fusions, Rachats

Blue Moon Metals To Acquire Apex Germanium Mine From Teck Subsidiary

27 févr. 2026, 17:55 UTC

Actions en Tendance

Toronto Stocks Decline, But Remain On Track for Weekly Gains

27 févr. 2026, 23:46 UTC

Acquisitions, Fusions, Rachats

Netflix Walks Away a Winner After Losing Warner Bros. to Paramount -- Barrons.com

27 févr. 2026, 23:33 UTC

Acquisitions, Fusions, Rachats

Paramount Issuing $47 Billion of Equity at Nearly 20% Premium to Current Stock Price -- Barrons.com

27 févr. 2026, 21:50 UTC

Market Talk
Acquisitions, Fusions, Rachats

Tech, Media & Telecom Roundup: Market Talk

27 févr. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

27 févr. 2026, 21:30 UTC

Résultats

Solventum Beat Wall Street Earnings Estimates. The Stock Falls. -- Barrons.com

27 févr. 2026, 21:30 UTC

Market Talk
Acquisitions, Fusions, Rachats

Warner Terminates Netflix Deal, Ending Monthslong Saga -- Market Talk

27 févr. 2026, 21:20 UTC

Acquisitions, Fusions, Rachats

Blue Moon Metals to Buy Apex Germanium and Gallium Mine From Teck >BMM

27 févr. 2026, 21:17 UTC

Résultats

These Stocks Are Today's Movers: Netflix, Paramount, Block, Sunrun, Dell, Rocket Lab, Nvidia, CoreWeave, and More -- Barrons.com

27 févr. 2026, 21:10 UTC

Acquisitions, Fusions, Rachats

Blue Moon Metals Evaluating Options for a New Processing Line at Springer Complex to Process the Apex Material

27 févr. 2026, 21:09 UTC

Acquisitions, Fusions, Rachats

Blue Moon Metals to Acquire the Apex Germanium and Gallium Mine From Teck

27 févr. 2026, 21:00 UTC

Résultats

Nike: 3Q Results to Be Released March 31 to Accommodate for Several Holidays >NKE

27 févr. 2026, 20:31 UTC

Acquisitions, Fusions, Rachats

Netflix Receives $2.8B Termination Fee Under Terminated Warner Bros. Discovery Deal

27 févr. 2026, 20:24 UTC

Market Talk

Oil Gains on Increased Risk of U.S.-Iran Conflict -- Market Talk

27 févr. 2026, 20:23 UTC

Market Talk

U.S. Natural Gas Futures Post Modest Gains -- Market Talk

27 févr. 2026, 20:12 UTC

Market Talk

Nike Seen With Further Challenges in China -- Market Talk

27 févr. 2026, 19:44 UTC

Market Talk

Gold Caps Historic Month -- Market Talk

27 févr. 2026, 19:39 UTC

Résultats

These Stocks Are Today's Movers: Netflix, Paramount, Block, Sunrun, Dell, Rocket Lab, Nvidia, CoreWeave, and More -- Barrons.com

27 févr. 2026, 19:38 UTC

Résultats

Earnings Could Push the Stock Market Higher. Too Bad About Everything Else. -- Barrons.com

27 févr. 2026, 18:53 UTC

Acquisitions, Fusions, Rachats

Largest U.S. Pension Takes Stake in a Hot Semi Stock, Buys More Nvidia and IonQ -- Barrons.com

27 févr. 2026, 18:45 UTC

Résultats

Quantum Computing Is No Longer a Speculative Bet. IonQ's Surging Stock Drives Home That Point. -- Barrons.com

27 févr. 2026, 18:45 UTC

Market Talk

Bitcoin Stays Vulnerable in Choppy Geopolitical Situation -- Market Talk

27 févr. 2026, 17:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

27 févr. 2026, 17:07 UTC

Résultats

Pemex Cuts 4Q Loss As Operating Results Improve

27 févr. 2026, 17:00 UTC

Market Talk

Corn Rides Oil Momentum Higher -- Market Talk

27 févr. 2026, 16:31 UTC

Market Talk

Canadian Economy Shows Resilience -- Market Talk

27 févr. 2026, 16:17 UTC

Market Talk

Canada Economy is Struggling But More Rate Cuts Still a Long Shot -- Market Talk

27 févr. 2026, 15:49 UTC

Résultats

Quantum Computing No Longer a Speculative Bet. IonQ's Surging Stock Drives Home That Point. -- Barrons.com

Comparaison

Variation de prix

Cencora Inc prévision

Objectif de Prix

By TipRanks

14.14% hausse

Prévisions sur 12 Mois

Moyen 418.5 USD  14.14%

Haut 440 USD

Bas 400 USD

Basé sur 9 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

9 ratings

8

Achat

1

Maintien

0

Vente

Sentiment

By Acuity

80 / 352Classement par Soins de santé

Sentiment de l'Actualité

Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Cencora Inc

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
help-icon Live chat